Prevalence and Predictors of Persistent Symptoms After Clearance of SARS-CoV-2 Infection: A Multicenter Study from Egypt

References

• Zhou P, Yang XL, Wang XG, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579(7798):270–273. doi:10.1038/s41586-020-2012-7
   PubMed Web of Science ®Google Scholar
• Abd Ellah NH, Gad SF, Muhammad K, Batiha EG, Hetta HF. Nanomedicine as a promising approach for diagnosis, treatment and prophylaxis against COVID-19. Nanomedicine. 2020;15(21):2085–2102. doi:10.2217/nnm-2020-0247
   PubMed Web of Science ®Google Scholar
• Abid SA, Muneer AA, Al-Kadmy IM, et al. Biosensors as a future diagnostic approach for COVID-19. Life Sci. 2021;273:119117. doi:10.1016/j.lfs.2021.119117
   PubMed Web of Science ®Google Scholar
• Xiao F, Tang M, Zheng X, Liu Y, Li X, Shan HJG. Evidence for gastrointestinal infection of SARS-CoV-2. Gastroenterology. 2020;158(6):1831–1833. e1833. doi:10.1053/j.gastro.2020.02.055
   PubMed Web of Science ®Google Scholar
• Mahmood Z, Alrefai H, Hetta HF, et al. Investigating virological, immunological, and pathological avenues to identify potential targets for developing covid-19 treatment and prevention strategies. Vaccines. 2020;8(3):443. doi:10.3390/vaccines8030443
   Web of Science ®Google Scholar
• Moubarak M, Kasozi KI, Hetta HF, et al. The rise of SARS-CoV-2 variants and the role of convalescent plasma therapy for management of infections. Life. 2021;11(8):734. doi:10.3390/life11080734
   PubMedGoogle Scholar
• Almaghaslah D, Kandasamy G, Almanasef M, Vasudevan R, Chandramohan S. Review on the coronavirus disease (COVID-19) pandemic: its outbreak and current status. Int J Clin Pract. 2020;74(11):e13637. doi:10.1111/ijcp.13637
   Web of Science ®Google Scholar
• Abdellatif AA, Tawfeek HM, Abdelfattah A, Batiha GE-S, Hetta HF. Recent updates in COVID-19 with emphasis on inhalation therapeutics: nanostructured and targeting systems. J Drug Deliv Sci Technol. 2021;63:102435. doi:10.1016/j.jddst.2021.102435
   PubMed Web of Science ®Google Scholar
• Dai W, Chen X, Xu X, et al. Clinical characteristics of asymptomatic patients with SARS-CoV-2 in Zhejiang: an imperceptible source of infection. Can Respir J. 2020;2020:2045341. doi:10.1155/2020/2045341
   Web of Science ®Google Scholar
• Magdy Beshbishy A, Hetta HF, Hussein DE, et al. Factors associated with increased morbidity and mortality of obese and overweight COVID-19 patients. Biology. 2020;9(9):280. doi:10.3390/biology9090280
   PubMed Web of Science ®Google Scholar
• Beshbishy AM, Oti VB, Hussein DE, et al. Factors behind the higher COVID-19 risk in diabetes: a critical review. Front Public Health. 2021;9:591982.
   Web of Science ®Google Scholar
• Koneru G, Batiha GE-S, Algammal AM, et al. BCG vaccine-induced trained immunity and COVID-19: protective or bystander? Infect Drug Resist. 2021;14:1169. doi:10.2147/IDR.S300162
   PubMed Web of Science ®Google Scholar
• Iltaf S Sr., Fatima M, Salman S Sr., Salam JU, Abbas S. Frequency of neurological presentations of coronavirus disease in patients presenting to a tertiary care hospital during the 2019 coronavirus disease pandemic. Cureus. 2020;12(8):e9846. doi:10.7759/cureus.9846
   PubMed Web of Science ®Google Scholar
• Laszkowska M, Faye AS, Kim J, et al. Disease course and outcomes of COVID-19 among hospitalized patients with gastrointestinal manifestations. Clin Gastroenterol Hepatol. 2020;19(7):1402–1409.
   Web of Science ®Google Scholar
• Alsharif W, Qurashi A. Effectiveness of COVID-19 diagnosis and management tools: a review. Radiography. 2021;27(2):682–687. doi:10.1016/j.radi.2020.09.010
   Web of Science ®Google Scholar
• Islam MF, Cotler J, Jason LA. Post-viral fatigue and COVID-19: lessons from past epidemics. Fatigue. 2020;8(2):61–69.
   Web of Science ®Google Scholar
• World Health Organization. A clinical case definition of post COVID-19 condition by a Delphi consensus, 6 October 2021; 2021.
   Google Scholar
• Dar HA, Waheed Y, Najmi MH, et al. Multiepitope subunit vaccine design against COVID-19 based on the spike protein of SARS-CoV-2: an in silico analysis. J Immunol Res. 2020;2020:8893483. doi:10.1155/2020/8893483
   PubMed Web of Science ®Google Scholar
• Collaborative G, Collaborative C. SARS-CoV-2 vaccination modelling for safe surgery to save lives: data from an international prospective cohort study. Br J Surg. 2021;108(9):1056–1063.
   Web of Science ®Google Scholar
• Tenforde MW, Kim SS, Lindsell CJ, et al. Symptom duration and risk factors for delayed return to usual health among outpatients with COVID-19 in a multistate health care systems network—United States, March–June 2020. MMWR Morb Mortal Wkly Rep. 2020;69(30):993. doi:10.15585/mmwr.mm6930e1
   PubMed Web of Science ®Google Scholar
• Carfì A, Bernabei R, Landi F; Group ftGAC-P-ACS. Persistent symptoms in patients after acute COVID-19. JAMA. 2020;324(6):603–605. doi:10.1001/jama.2020.12603
   PubMed Web of Science ®Google Scholar
• Goërtz YMJ, Van Herck M, Delbressine JM, et al. Persistent symptoms 3 months after a SARS-CoV-2 infection: the post-COVID-19 syndrome? ERJ Open Res. 2020;6(4):00542–02020. doi:10.1183/23120541.00542-2020
   PubMedGoogle Scholar
• Garner P. Covid-19 and fatigue—a game of snakes and ladders; 2020.
   Google Scholar
• Callard F, Perego E. How and why patients made Long Covid. Soc Sci Med. 2021;268:113426. doi:10.1016/j.socscimed.2020.113426
   PubMed Web of Science ®Google Scholar
• Davido B, Seang S, Tubiana R, de Truchis P. Post-COVID-19 chronic symptoms: a postinfectious entity? Clin Microbiol Infect. 2020;26(11):1448–1449. doi:10.1016/j.cmi.2020.07.028
   PubMed Web of Science ®Google Scholar
• Halpin SJ, McIvor C, Whyatt G, et al. Postdischarge symptoms and rehabilitation needs in survivors of COVID-19 infection: a cross-sectional evaluation. J Med Virol. 2021;93(2):1013–1022.
   PubMed Web of Science ®Google Scholar
• Romero-Sánchez CM, Díaz-Maroto I, Fernández-Díaz E, et al. Neurologic manifestations in hospitalized patients with COVID-19: the ALBACOVID registry. Neurology. 2020;95(8):e1060–e1070. doi:10.1212/WNL.0000000000009937
   PubMed Web of Science ®Google Scholar
• Papadopoulos AS, Cleare A. Hypothalamic–pituitary–adrenal axis dysfunction in chronic fatigue syndrome. Nature Rev Endocrinol. 2012;8(1):22–32.
   Web of Science ®Google Scholar
• Sandler CX, Wyller VB, Moss-Morris R, et al. Long COVID and post-infective fatigue syndrome: a review. Paper presented at: Open forum infectious diseases; 2021.
   Google Scholar
• Wang X, Xu H, Jiang H, et al. Clinical features and outcomes of discharged coronavirus disease 2019 patients: a prospective cohort study. QJM. 2020;113(9):657–665. doi:10.1093/qjmed/hcaa178
   PubMed Web of Science ®Google Scholar
• Hotchin NA, Read R, Smith DG, Crawford DH. Active Epstein-Barr virus infection in post-viral fatigue syndrome. J Infect. 1989;18(2):143–150.
   Web of Science ®Google Scholar
• Tansey CM, Louie M, Loeb M, et al. One-year outcomes and health care utilization in survivors of severe acute respiratory syndrome. Arch Intern Med. 2007;167(12):1312–1320. doi:10.1001/archinte.167.12.1312
   PubMedGoogle Scholar
• Petrie JG, Cheng C, Malosh RE, et al. Illness severity and work productivity loss among working adults with medically attended acute respiratory illnesses: US influenza vaccine effectiveness network 2012–2013. Clin Infect Dis. 2016;62(4):448–455. doi:10.1093/cid/civ952
   PubMed Web of Science ®Google Scholar
• Wootton DG, Dickinson L, Pertinez H, et al. A longitudinal modelling study estimates acute symptoms of community acquired pneumonia recover to baseline by 10 days. Eur Respir J. 2017;49(6):1602170. doi:10.1183/13993003.02170-2016
   Web of Science ®Google Scholar
• Wyrwich KW, Yu H, Sato R, Powers JH. Observational longitudinal study of symptom burden and time for recovery from community-acquired pneumonia reported by older adults surveyed nationwide using the CAP Burden of Illness Questionnaire. Patient Relat Outcome Meas. 2015;6:215–223. doi:10.2147/PROM.S85779
   PubMedGoogle Scholar
• Garrigues E, Janvier P, Kherabi Y, et al. Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19. J Infect. 2020;81(6):e4–e6. doi:10.1016/j.jinf.2020.08.029
   PubMed Web of Science ®Google Scholar
• Srivastava A, Bala R, Devi TP, Anal L. Psychological trauma and depression in recovered COVID-19 patients: a telecommunication based observational study. Trends Psychiatry Psychother. 2021. doi:10.47626/2237-6089-2021-0381
   Google Scholar
• Whittaker A, Anson M, Harky A. Neurological manifestations of COVID‐19: a systematic review and current update. Acta Neurol Scand. 2020;142(1):14–22. doi:10.1111/ane.13266
   PubMed Web of Science ®Google Scholar
• Hernández-Fernández F, Valencia HS, Barbella-Aponte RA, et al. Cerebrovascular disease in patients with COVID-19: neuroimaging, histological and clinical description. Brain. 2020;143(10):3089–3103. doi:10.1093/brain/awaa239
   PubMed Web of Science ®Google Scholar
• Craparo G, La Rosa VL, Marino G, et al. Risk of post-traumatic stress symptoms in hospitalized and non-hospitalized COVID-19 recovered patients. A cross-sectional study. Psychiatry Res. 2022;308:114353. doi:10.1016/j.psychres.2021.114353
   Web of Science ®Google Scholar
• Toubiana J, Poirault C, Corsia A, et al. Kawasaki-like multisystem inflammatory syndrome in children during the covid-19 pandemic in Paris, France: prospective observational study. BMJ. 2020;369:m2094. doi:10.1136/bmj.m2094
   PubMed Web of Science ®Google Scholar
• DHL Ng, CY Choy, YH Chan, et al. Fever patterns, cytokine profiles, and outcomes in COVID-19. Open Forum Infect Dis. 2020;7(9):ofaa375.
   Web of Science ®Google Scholar
• Chen D, Xu W, Lei Z, et al. Recurrence of positive SARS-CoV-2 RNA in COVID-19: a case report. Int J Infect Dis. 2020;93:297–299. doi:10.1016/j.ijid.2020.03.003
   PubMed Web of Science ®Google Scholar
• Cheung KS, Hung IFN, Chan PPY, et al. Gastrointestinal manifestations of SARS-CoV-2 infection and virus load in fecal samples from a Hong Kong cohort: systematic Review and meta-analysis. Gastroenterology. 2020;159(1):81–95. doi:10.1053/j.gastro.2020.03.065
   PubMed Web of Science ®Google Scholar
• Parasa S, Desai M, Thoguluva Chandrasekar V, et al. Prevalence of gastrointestinal symptoms and fecal viral shedding in patients with coronavirus disease 2019: a systematic review and meta-analysis. JAMA Netw Open. 2020;3(6):e2011335. doi:10.1001/jamanetworkopen.2020.11335
   PubMed Web of Science ®Google Scholar
• Kecler-Pietrzyk A, Orsi G, Carthy J, Torreggiani WC. Enteritis and severe abdominal pain as the first presentation of Covid-19. Ir Med J. 2020;113(6):102.
   Google Scholar
• Al-Aly Z, Xie Y, Bowe BJN. High-dimensional characterization of post-acute sequelae of COVID-19. Nature. 2021;594(7862):259–264. doi:10.1038/s41586-021-03553-9
   PubMed Web of Science ®Google Scholar
• Ayoubkhani D, Khunti K, Nafilyan V, et al. Post-covid syndrome in individuals admitted to hospital with covid-19: retrospective cohort study. BMJ. 2021:372. doi:10.1136/bmj.n693
   Web of Science ®Google Scholar
• Lam MH, Wing YK, Yu MW, et al. Mental morbidities and chronic fatigue in severe acute respiratory syndrome survivors: long-term follow-up. Arch Intern Med. 2009;169(22):2142–2147. doi:10.1001/archinternmed.2009.384
   PubMedGoogle Scholar
• Donnelly JP, Wang XQ, Iwashyna TJ, Prescott H. Readmission and death after initial hospital discharge among patients with COVID-19 in a large multihospital system. JAMA. 2021;325(3):304–306. doi:10.1001/jama.2020.21465
   PubMed Web of Science ®Google Scholar